The Leaflex™ Standalone Study Protocol

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A prospective, multicenter, single-arm study aimed to assess safety and performance of the Leaflex™ Performer in the treatment of patients with symptomatic, severe aortic stenosis. Subjects will be seen at pre- and post procedure, discharge, 30 days and at 3, 6, 9 and 12 months post procedure.
Epistemonikos ID: 22cc8f193e4299d1ae4932320922aac25b3e996c
First added on: May 07, 2024